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Abstract
Fulminant myocarditis frequently results in severe hemodynamic deterioration. High-dose vasopressors or
sometimes mechanical circulatory support are required. We report on two cases of fulminant myocarditis
successfully treated with pulsatile extracorporeal life support (T-PLS
®, Twin Pulse Life support, New heart bio.BHK,
Seoul, Korea). With T-PLS, we were able to provide mechanical support to patients until they recovered completely.
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Introduction
We report on two cases of fulminant myocarditis. They
developed profound hypoxemia, acidosis, pulmonary
edema, and oliguria. T-PLS
®(Twin Pulse Life support,
New heart bio.BHK, Seoul, Korea) was used in order to
prevent further deterioration. Both patients recovered
well from fulminant myocarditis with T-PLS support.
Echocardiograms showed normal ejection fraction after
recovery. Written informed consent was obtained from
the patient for publication of this case report and
accompanying images. A copy of the written consent is
available for review by the Editor-in-Chief of this
journal.
Case 1
A 32-year-old woman without previous medical history
was referred to the emergency department with dizzi-
ness for one day. On admission, the vital signs were
unstable, with a blood pressure of 70/40 mmHg, heart
rate of 91 beats/min, and body temperature of 35.4°C.
White blood cell count was 16,470 10
9/L and troponin I
was 2.563 ng/mL. Arterial blood gas analysis showed
metabolic acidosis. EKG demonstrated sinus tachycardia.
Hemodynamic status showed rapid deterioration during
the subsequent hours. Systolic blood pressure was below
90 mmHg, with a heart rate faster than 100 beats/min.
Urine output decreased, too. Hypoxemia did not resolve
with supplementary oxygen. Echocardiogram showed a
left ventricular ejection fraction of 21% with global
hypokinesia. She was admitted to the intensive care unit
(ICU) with a diagnosis of probable viral myocarditis.
Ventilator therapy was initiated. She developed atrial
fibrillation with rapid ventricular response. Hemody-
namic status showed further worsening. Urine output
further decreased and she developed hypoxemia with
pulmonary edema, lactic acidosis. On the second day of
admission, we decided to place the patient on a T-PLS.
A 17 French femoral venous and a 14 French arterial
cannula were inserted percutaneously. The pump was
started with a flow of 2.13 L/min/m
2, a pump rate of
47/min, and 100% oxygen at 4 L/min. The membrane
oxygenator was replaced as required when oxygenation
is not adequate (PaO2 < 100 with FiO2 of 1.0) due to
plasma leakage. Serial chest X-rays showed improving
pulmonary edema after T-PLS insertion (Figure 1). On
day 10, T-PLS was weaned down slowly and removed.
Changes of inotropic agent and pump flow rate are
shown in Table 1. Blood serology showed elevated titers
of Coxsackievirus B4(1:64), Coxsackievirus B2(1:16),
Coxsackievirus B3.5(1:8), and Adenovirus IgM. Six days
after removal of T-PLS, echocardiography showed
improved cardiac function (LVEF of 68%) with minimal
pericardial effusion. The patient was discharged on the
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was normal, with LVEF of 64%.
Case 2
A 36-year-old women with a history of cardiac surgery
for treatment of Tetralogy of fallot 35 years ago and
dextrocardia presented to the emergency department
with fever and dyspnea for 2 days. On admission, blood
pressure was 70/50 mmHg, pulse rate was 120 beats/
min, and body temperature was 36.5°C. White blood
cell count was 16,470 10
9/L. EKG demonstrated sinus
tachycardia and chest radiography showed pulmonary
edema. Troponin I was elevated to 13.72 ng/mL. Echo-
cardiogram showed depressed global left ventricular
ejection fraction(28%). The patient was admitted to the
intensive care unit. Nine hours after admission, troponin
I increased to 42.459 ng/mL. She developed hypoxemia
and hemodynamic status showed rapid deterioration
with acidosis, oliguria during the subsequent hours,
despite a high dose of inotropics and vasopressors. The
patient was intubated and T-PLS was initiated with a
percutaneous 17 French femoral venous and a 14
French arterial cannula. The pump started with a flow
of 1.69 L/min/m
2, a pump rate of 70/min, and 100%
oxygen flow at 5 L/minute. Arterial blood from the right
radial artery was 100% after T-PLS insertion and the
patient could be extubated. The membrane oxygenator
was replaced on the 3rd, 6
th,a n d9
th days when oxyge-
nation was not adequate. On day 12, blood pressure was
100/60 mmHg, and pulse rate was 80 beats/min, with a
T-PLS flow of 1.75 L/min/m
2. White blood cell count
decreased to 9,240 10
9/L, and troponin I decreased to
0.130 ng/ml. Arterial blood gas analysis was satisfactory.
Left ventricular systolic function (LVEF 52%) and chest
x-ray (Figure 1) were much improved. T-PLS was
weaned slowly down to off and removed successfully as
shown in Table 1. Blood serology showed elevated titers
of Coxsackie virus B4 (1:64) and Coxsackie virus B3
(1:32). Forty two days after TPLS, echocardiography
showed normal systolic function (LVEF 57%) with mild
pericardial effusion. Twelve months later, echocardiogra-
phy showed normal cardiac function (LVEF 60%).
Discussion
Fulminant myocarditis is an inflammation of the myo-
cardium, which is caused by viral, bacterial, or protozoal
infections, drug toxicity, or immunological reaction [1].
Fulminant myocarditis is characterized by acute onset
with severe hemodynamic deterioration. Diagnosis of
fulminant myocarditis in the early stages of the disease
may be difficult. It may be initially misdiagnosed as sep-
tic shock, in which myocardial dysfunction and mild
troponin I elevation are commonly seen [1,2]. Fulminant
myocarditis is different from acute myocarditis in its
clinical features [1,3]. Fulminant myocarditis was diag-
nosed on the basis of clinical features at presentation,
including the presence of severe hemodynamic
Figure 1 Chest x-ray comparison of both cases.a .C a s e1 ,3
rd
day of T-PLS. b. Case 1, 10
th day of T-PLS, day of weaning. c. Case 2,
2
nd day of T-PLS. d. Case 2, 13
th day of T-PLS, one day after
weaning.
Table 1 Inotropics support and T-PLS setting for the initial and weaning period
Inotropics T-PLS settings
Norepi
(μg/min)
Dopa
(μg/kg/min)
Dobuta
(μg/kg/min)
Flow
(L/min)
Pump rate
(rate/min)
Oxygen
(L/min)
Case 1 Initial 30 50 15 2.13 47 4
Weaning 0 4 5 1.07 33 2
Case 2 Initial 30 40 30 1.69 70 5
Weaning 0 15 6 1.07 33 1.5
Norepi, Norepinephrine; Dopa, Dopamine; Dobuta, Dobutamine
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the other hand, acute myocarditis usually shows less
severe hemodynamic compromise and did not have
these features [3,4].
There is no specific treatment for fulminant myocardi-
tis. Thus, treatment remains supportive. Physicians sus-
pecting fulminant myocarditis must be prepared to use
therapeutic options, such as mechanical circulatory sup-
port, prior to occurrence of severe organ failure [1,5,6].
With appropriate treatment, fulminant myocarditis is
commonly reversible within a few days and is associated
with better long-term prognosis than acute myocarditis
[3].
Mechanical circulatory support in myocarditis is used
for maintenance of cardiac output and organ perfusion,
and to minimize the need for inotropic support until
myocardial recovery. There are several methods for
mechanical circulatory support. These include the intra-
aortic balloon pump, non-pulsatile extracorporeal life
support, and pulsatile extracorporeal life support, such
as T-PLS, which we used for our cases, and ventricular
assist devices.
A non-pulsatile pump has advantages over a pulsatile
pump in that it maintains regular blood pressure with
less hemolysis during total extracorporeal circulation.
However, it does not maintain higher pulse pressure or
mean blood pressure than the pulsatile pump [7-9],
which probably results in less tissue perfusion [10].
T-PLS has an actuator and two blood sacs, and the
reciprocating actuator pushes on the blood sacs alterna-
tively, causing pulsatile flow (Figure 2). The T-PLS sys-
tem has an effective pulsatility in hemodynamic energy
and provides a beneficial effect on the coronary arteries
in terms of blood flow, flow velocity, and resistance, and
also provides better tissue perfusion than the non-pulsa-
tile pump [10,11]. Compared to other pulsatile pumps
with different pulse generating mechanisms, the dual sac
structure of T-PLS can effectively reduce high mem-
brane oxygenator inlet pressure, and, thus, reduce
hemolysis [7,8,12,13].
T-PLS is not synchronized with native heart beat.
When it is used in severe heart failure patient where
there is very low pulsatility from the heart, no synchro-
nization is required. When the heart is recovered and
makes higher pulsatility, T-PLS rate is weaned down so
that it does not eject too strongly when the heart ejects.
As proven by previous studies, T-PLS can improve
coronary and other tissue perfusion with less hemolysis
[7,8,12], and those advantages are essential for treatment
of fulminant myocarditis; therefore, we think that T-PLS
is one of the most suitable treatment options for fulmi-
nant myocarditis.
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Figure 2 Schematic diagram of T-PLS. a. Connection to patient. b. Action mechanism; the reciprocating actuator pushes on blood sacs
alternatively, causing pulsatile flow
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